You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PF-07901801

Showing 1 - 25 of 1,083
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DLBCL Trial (maplirpacept (PF-07901801), Glofitamab, Obinutuzumab)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • maplirpacept (PF-07901801)
  • +2 more
  • (no location specified)
May 30, 2023

DLBCL Trial in San Juan (PF-07901801, Tafasitamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • PF-07901801
  • +2 more
  • San Juan, Puerto Rico
    Auxilio Mutuo Cancer Center
Jan 19, 2023

Non-Hodgkin Lymphoma, Multiple Myeloma Trial in China (Maplirpacept)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • Beijing, Beijing, China
  • +3 more
May 31, 2023

Lymphoma, Multiple Myeloma Trial in Nagoya, Koto, Yamagata (TTI-622)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • Nagoya, Aichi, Japan
  • +2 more
Jan 20, 2023

Healthy Participants Trial (Single dose of PF-07220060 as first Tablet Formulation, Single dose of PF-07220060 as second Tablet

Not yet recruiting
  • Healthy Participants
  • Single dose of PF-07220060 as first Tablet Formulation
  • +3 more
  • (no location specified)
Jun 20, 2023

Atopic Dermatitis Trial in United States (PF-07275315, PF-07264660, Placebo)

Not yet recruiting
  • Atopic Dermatitis
  • Huntington Beach, California
  • +3 more
Aug 21, 2023

Healthy Trial (PF-07976016, Placebo, Midazolam)

Not yet recruiting
  • Healthy
  • (no location specified)
Oct 24, 2023

Hemiparesis;Poststroke/CVA Trial in Créteil (Eccentric training, Conventional therapy)

Recruiting
  • Hemiparesis;Poststroke/CVA
  • Eccentric training
  • Conventional therapy
  • Créteil, France
    Wael Maktouf
Nov 16, 2023

Healthy Trial in New Haven, Brussels (PF-07817883, Placebo, Midazolam)

Recruiting
  • Healthy
  • New Haven, Connecticut
  • +1 more
Dec 19, 2022

Pulmonary Arterial Hypertension Trial (PF-07868489, Placebo for PF-07868489)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • (no location specified)
Nov 14, 2023

Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • +5 more
  • (no location specified)
Jun 7, 2023

Healthy Trial in New Haven (PF-07328948, Placebo)

Recruiting
  • Healthy
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jan 5, 2023

Hemolysis During Pulsed-field and Radiofrequency Ablation

Not yet recruiting
  • Atrial Fibrillation
  • +2 more
  • Pulsed-field ablation
  • Radiofrequency ablation
  • Prague, Czechia
    Cardiocenter, 3rd Medical School, Charles University and Univers
Oct 20, 2023

Healthy Trial (PF-07817883, Itraconazole)

Not yet recruiting
  • Healthy
  • (no location specified)
Apr 10, 2023

Presbyopia Trial in Crystal River (BRIMOCHOL™ PF, Carbachol PF, Vehicle)

Recruiting
  • Presbyopia
  • BRIMOCHOL™ PF
  • +2 more
  • Chandler, Arizona
  • +42 more
Sep 30, 2022

Pelvic Floor Disorders Trial in Palma De Mallorca (Pelvic floor muscle training with biofeedback device, Pelvic floor muscle

Not yet recruiting
  • Pelvic Floor Disorders
  • Pelvic floor muscle training with biofeedback device
  • +2 more
  • Palma De Mallorca, Balearic Islands, Spain
    University of the Balearic Islands
Aug 29, 2023

Overweight, Obesity Trial in New Haven (Formulation A (PF-07081532 20 mg plus 60 mg), Formulation B (PF-07081532 80 mg))

Recruiting
  • Overweight
  • Obesity
  • Formulation A (PF-07081532 20 mg plus 60 mg)
  • Formulation B (PF-07081532 80 mg)
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Jan 25, 2023

Breast Cancer, Solid Tumors Trial in Boston, Grand Rapids, Houston (PF-07220060 + PF-07104091 combination dose escalation,

Recruiting
  • Breast Cancer
  • Solid Tumors
  • PF-07220060 + PF-07104091 combination dose escalation
  • +2 more
  • Grand Rapids, Michigan
  • +1 more
Jun 28, 2022

Renal Impairment Trial (Drug: PF-07923568)

Not yet recruiting
  • Renal Impairment
  • Drug: PF-07923568
  • (no location specified)
Sep 7, 2023

COVID-19 Trial in Denmark, United States (PF-07304814, Placebo, Remdesivir)

Suspended
  • COVID-19
  • Chula Vista, California
  • +39 more
Mar 22, 2023

Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer,

Recruiting
  • Locally Advanced or Metastatic ER+ HER2- Breast Cancer
  • +2 more
  • Scottsdale, Arizona
  • +45 more
Dec 11, 2022

Crohn's Disease Trial in Worldwide (PF-06651600 Placebo, PF-06651600, Placebo PF-06700841)

Active, not recruiting
  • Crohn's Disease
  • PF-06651600 Placebo
  • +3 more
  • Dothan, Alabama
  • +187 more
Aug 17, 2022

Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)

Recruiting
  • Advanced Solid Tumors
  • +5 more
  • Scottsdale, Arizona
  • +7 more
Jan 23, 2023

Plantar Fasciitis Trial in Boston (Orthotic)

Terminated
  • Plantar Fasciitis
  • Orthotic
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 31, 2023

Acne Inversa Trial in Australia, Canada, United States (PF-06650833, PF-06700841, PF-06826647)

Completed
  • Acne Inversa
  • Birmingham, Alabama
  • +76 more
Jul 10, 2022